Patent · US Expired

JAK-3 inhibitors for treating allergic disorders

US6080747A · kind A · utility

100Cited by
6References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 5, 1999
Grant dateJun 27, 2000
Priority date
Expiry dateMar 5, 2019

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Inhibitors of JAK3 kinase for the treatment of allergy inhibit mast cell degranulation an dmediator release.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.